Hill D P, Poore S, Wilson J, Robson M C, Cherry George W
The Institute for Tissue Regeneration, Repair, and Rehabilitation, Bay Pines Veterans Administration Medical Center, Bay Pines, Florida, USA.
Am J Surg. 2004 Jul;188(1A Suppl):22-5. doi: 10.1016/S0002-9610(03)00287-3.
Clinical trials that follow venous ulcers to complete healing can be costly because of the prolonged healing time involved. Initial healing rates in venous ulcers are calculated by 2 methods, which are based on a metric using wound area and perimeter. It has been proposed that these rates allow the prediction of complete healing and that they may be useful as surrogate end points for clinical trials. The objective of this study was to compare the 2 proposed methods for calculating initial healing rates and determine their usefulness in predicting the healing of venous ulcers. Venous leg ulcers from patients enrolled in a randomized, double-blind, placebo-controlled study were measured weekly for up to 12 weeks. Their healing status was determined for up to 24 weeks. Initial healing rates were calculated using the 2 proposed methods. The ability of these rates to predict time to complete healing was assessed. Information from 17 patients was available. The initial healing rates, calculated by either method, were quite similar; both methods produced the same median value of 0.046 cm/week in our patients. Five of the patients had negative initial healing rates, which do not allow any prediction of a healing time. Three of 7 patients predicted to heal within 24 weeks failed to do so. One of the 5 patients was predicted to heal at some time after 24 weeks but actually healed within 24 weeks. None of the 5 patients with negative initial healing rates healed within 24 weeks. Initial healing rates, as calculated by either method, have limited utility in describing healing curves and predicting a healing time. This poor predictive ability argues against using these initial healing rates as surrogate end points for clinical trials. The great variability observed in venous ulcer healing curves may limit the development of useful predictive models in this patient population.
由于静脉溃疡愈合时间较长,跟踪其完全愈合的临床试验成本可能很高。静脉溃疡的初始愈合率通过两种方法计算,这两种方法基于使用伤口面积和周长的指标。有人提出,这些比率可以预测完全愈合情况,并且它们可能作为临床试验的替代终点有用。本研究的目的是比较两种计算初始愈合率的方法,并确定它们在预测静脉溃疡愈合方面的有用性。对参加随机、双盲、安慰剂对照研究的患者的下肢静脉溃疡每周测量一次,最长测量12周。确定其愈合状态最长达24周。使用两种提议的方法计算初始愈合率。评估这些比率预测完全愈合时间的能力。获得了17名患者的信息。通过任何一种方法计算的初始愈合率都非常相似;在我们的患者中,两种方法得出的中位数均为0.046厘米/周。5名患者的初始愈合率为负值,这无法预测愈合时间。预计在24周内愈合的7名患者中有3名未能愈合。5名患者中有1名预计在24周后某个时间愈合,但实际上在24周内愈合。5名初始愈合率为负值的患者在24周内均未愈合。通过任何一种方法计算的初始愈合率在描述愈合曲线和预测愈合时间方面的效用有限。这种较差的预测能力表明不适合将这些初始愈合率用作临床试验的替代终点。在静脉溃疡愈合曲线中观察到的巨大变异性可能会限制该患者群体中有用预测模型的开发。